1. Gabow PA.Autosomal dominanı polycystic kidney disease. N EnglJMed. 1993;329:332-342.
2. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol. 2001;12:194-200.
3. Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Du-ley IT, Gabow PA, Schrier RW.Progress in blood pressure control in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;36:266-271.
4. Gibson P, Watson ML.Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant. 1998;13:2455-2457.
5. Bajwa ZH, Gupta S, Warfield CA, Steinman TLPain management in polycystic kidney disease. Kidney Int. 2001;60:1631-1644.
6. Grampsas SA, Ghandhoke PS, Fan J, Glass MA, Townsend K. Johnson AM, Gabow P.Anaiomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;36:53-57.
7. Fried LF, Palevsky PM, Johnston JR.Duodenal obstruction in polycystic kidney disease. Case report and review of the literature. Am J Nephrol. 1998;18:318-820.
8. Perrone RD.Extrarenal manifestations of ADPKD. Kidney Int. 1997;51:2022-2036
9. Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J 3rd, Shub C, Davila S, Somlo S, Torres VE. Clinical profile of autosomal dominant polycystic liver disease. Hepatology. 2003;37:164-171.
10. Dedi R, Bhandari S, Turney JH, Brownjohn AM, Eardley I.Lesson of the week: Causes of haematuria in adult polycystic kidney disease. BMJ. 2001;323:386-387.
11. Ng CS, Yost A. Streem SB.Nephrolithiasis associated wilh autosomal dominant polycystic kidney disease; contemporary urological management. J Urol. 2000;163:726-729.
12. Dunn MD, Portis AJ, Naughton C, Shalhav A, McDougall EM. Clayman RV Laparoscopic cyst marsupialization in patients with autosomal dominant polycystic kidney disease. J LIrol. 2001;165:1888-1892.
Thank you for copying data from http://www.arastirmax.com